Page last updated: 2024-08-26

3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine and Experimental Hepatoma

3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine has been researched along with Experimental Hepatoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, CD; Pratt, VS; Ryu, DY; Schut, HA; Snyderwine, EG1

Other Studies

1 other study(ies) available for 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine and Experimental Hepatoma

ArticleYear
In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
    Cancer research, 1999, Jun-01, Volume: 59, Issue:11

    Topics: Animals; Carcinogens; DNA Adducts; Female; Lac Operon; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Mice, Inbred DBA; Mice, Transgenic; Mutagens; Quinoxalines; Sequence Analysis, DNA; Sex Factors

1999